PeerVoice Endocrinology & Metabolic Disorders Audio

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

http://www.peervoice.com

Eine durchschnittliche Folge dieses Podcasts dauert 19m. Bisher sind 63 Folge(n) erschienen. Dieser Podcast erscheint alle 3 Wochen.

Gesamtlänge aller Episoden: 1 day 1 hour 7 minutes

subscribe
share





Clinical Conundrums in Type 2 Diabetes: Managing Challenging Cases in Primary Care


Clinical Conundrums in Type 2 Diabetes: Managing Challenging Cases in Primary Care


share







   25m
 
 

Optimising Use of Traditional Oral Glucose-Lowering Therapies in Type 2 Diabetes: Important for Patients and Society!


Optimising Use of Traditional Oral Glucose-Lowering Therapies in Type 2 Diabetes: Important for Patients and Society!


share







   17m
 
 

Treatment Gaps in T2DM and Obesity: Personalising Care for Better Outcomes


Treatment Gaps in T2DM and Obesity: Personalising Care for Better Outcomes


share







 2021-08-11  31m
 
 

Personalising Care Across the Disease Continuum: From Prediabetes Through Type 2 Diabetes


Personalising Care Across the Disease Continuum: From Prediabetes Through Type 2 Diabetes


share







 2021-08-07  44m
 
 

Evaluating the Evidence for SGLT2 Inhibition in CKD: Highlights From the 2021 Virtual ERA-EDTA Congress


Evaluating the Evidence for SGLT2 Inhibition in CKD: Highlights From the 2021 Virtual ERA-EDTA Congress


share







 2021-07-17  8m
 
 

Evaluating the Evidence for Managing CKD: Highlights From World Congress of Nephrology 2021


Evaluating the Evidence for Managing CKD: Highlights From World Congress of Nephrology 2021


share







 2021-06-24  8m
 
 

Step-by-Step: Setting a Course for Long-Term Control of Type 2 Diabetes With GLP-1 RAs


Step-by-Step: Setting a Course for Long-Term Control of Type 2 Diabetes With GLP-1 RAs


share







 2021-06-18  21m
 
 

Why Combination Therapies and Why Now? The Rationale and Role of GLP-1 RAs and Insulin


Why Combination Therapies and Why Now? The Rationale and Role of GLP-1 RAs and Insulin


share







 2021-06-11  32m
 
 

"Setting New Goals for Slowing Progression in Chronic Kidney Disease: What Is Possible With GLP-1 RAs?"


"Setting New Goals for Slowing Progression in Chronic Kidney Disease: What Is Possible With GLP-1 RAs?"


share







 2021-05-04  39m
 
 

Could PSMA Be the ‘Bulls-Eye’ Target in mCRPC?


Could PSMA Be the ‘Bulls-Eye’ Target in mCRPC?


share







 2021-05-01  19m